EPO Patents = 2

Forward Citations = 0

Loading Chart...

5 inventors (with patents filed for the assignee):

Peter Leonardi (3 out of 3 patents)

Elin Martina Pola (3 out of 3 patents)

Jeffrey Babad (3 out of 3 patents)

4. Myrtle Gordon (2 out of 2 patents)

5. Nagy Habib (1 out of 18 patents)

6. Nagy A Habib (0 patent)

5 patents: Sort by Forward Citations

1. 12133885 - Fusion proteins comprising modified alpha virus surface glycoproteins and tumor associated antigen and methods thereof (2024-11-05),

2. 11471518 - Fusion proteins comprising modified alpha virus surface glycoproteins and tumor associated antigen and methods thereof (2022-10-18),

3. 10660948 - Fusion proteins comprising modified alpha virus surface glycoproteins and tumor associated antigen and methods thereof (2020-05-26),

4. 9163234 - Culture method (2015-10-20),

5. 8652846 - Medium derived from stem cells as a pharmaceutical composition (2014-02-18),

Company Overview

Omnicyte Limited is a biotechnology company specializing in developing novel cell therapies for various diseases. With a focus on CAR-T cell therapy, they harness the power of the immune system to target and eliminate cancer cells. Their innovative approach has shown promising results in preclinical studies and clinical trials, offering hope for patients with previously untreatable conditions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#558 in London

#3,216 in United Kingdom

London, United Kingdom

Omnicyte Limited

Forward Citations = 0

5 inventors:

Peter Leonardi (3 out of 3 patents)

Elin Martina Pola (3 out of 3 patents)

Jeffrey Babad (3 out of 3 patents)

4. Myrtle Gordon (2 out of 2 patents)

5. Nagy Habib (1 out of 18 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Omnicyte Limited. Retrieved from https://idiyas.com/company/omnicyte

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]